secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXOZYMES INC. (EXOZ)
CIK:        0002010788
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0001493152-24-046545
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invizyne completes $15M IPO; shares begin trading on Nasdaq under IZTC
----------------------------------------------------------------------

- Priced 1,875,000 shares at $8.00; gross proceeds $15M, net proceeds ~$14.3M.
- Concurrent private placement issued 93,750 warrants at $0.125, exercisable at $8.00 for 5 years.
- Underwriter has 45-day option to purchase up to 281,250 additional shares for over-allotments.
- Net proceeds to fund production capacity, business development, repayment of related-party loan, and working capital.
- SAFEs from July 2023 converted into 125,001 shares of common stock upon IPO closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/0001493152-24-046545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-046545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer